In vivo selection of Klebsiella pneumoniae strains with enhanced quinolone resistance during fluoroquinolone treatment of urinary tract infections.
AUTOR(ES)
Deguchi, T
RESUMO
We report two cases of failure of fluoroquinolone treatment of urinary tract infections with Klebsiella pneumoniae strains harboring quinolone resistance-associated alterations in GyrA and ParC and in vivo selection of posttreatment isolates with enhanced fluoroquinolone resistance. Active efflux leading to decreased accumulation of a drug enhanced fluoroquinolone resistance in one posttreatment isolate, and an additional mutation in parC resulting in an additional amino acid change in ParC was associated with increased resistance in the other.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=163971Documentos Relacionados
- Recurrent urinary tract infections.
- Adhesion to a human cell line by Escherichia coli strains isolated during urinary tract infections.
- Amoxicillin plus clavulanic acid in the treatment of recurrent urinary tract infections.
- Urinary adenylate kinase and urinary tract infections.
- Comparison of moxalactam and gentamicin in the treatment of complicated urinary tract infections.
